Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PerioBiologics is a biotechnology company focused on developing and commercializing advanced regenerative solutions for periodontal and oral surgery applications. The company specializes in biologics that promote the healing and regeneration of bone and soft tissues affected by periodontal disease or trauma. Their product portfolio includes growth factors and bone grafting materials designed to enhance clinical outcomes in procedures such as dental implant placement and gingival recession repair. By leveraging expertise in tissue engineering and molecular biology, PerioBiologics aims to provide clinicians with more predictable and effective tools for oral rehabilitation. The company operates primarily within the dental specialty market, serving periodontists and oral surgeons.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PerioBiologics.